Found: 4
Select item for more details and to access through your institution.
Validation of diagnosis codes to identify hospitalized COVID‐19 patients in health care claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 4, p. 476, doi. 10.1002/pds.5401
- By:
- Publication type:
- Article
Capture of biologic and biosimilar dispensings in a consortium of U.S.‐based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 7, p. 778, doi. 10.1002/pds.4934
- By:
- Publication type:
- Article
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e248192, doi. 10.1001/jamanetworkopen.2024.8192
- By:
- Publication type:
- Article
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 Years.
- Published in:
- JAMA Pediatrics, 2023, v. 177, n. 7, p. 710, doi. 10.1001/jamapediatrics.2023.1440
- By:
- Publication type:
- Article